Dr. Ali M.  Ardekani

Dr. Ali M. Ardekani

Head of Academic Department/Faculty
Shahid Beheshti University, Iran


Highest Degree
Ph.D. in Endocrinology from Shahid Beheshti University, Iran

Share this Profile

Biography

Dr. Ali M. Ardekani is currently working as Associate Professor at National Institute of Genetic Engineering and Biotechnology Shahrake Pajoohesh, Tehran-Iran, and Director at Middle-Eastern Association for Cancer Research, Canada, and Health Biotechnology Convention Pasteur Institute of Iran. He obtained his Ph.D. in Endocrinology from Shahid Beheshti University, Iran. Dr. Ali M. Ardekani received honors includes Recipient of a 42,000.00 Grant from the International Center for Genetic Engineering and Biotechnology (ICGEB) from the country of Iran, Cancer Research Award, National Cancer Institute, USA, NIH Postdoctoral Training Grant, Northwestern University, IL, and AACR-AFLAC Scholar in Cancer Research Award. He is member of Iran National Cancer steering Committee and a founding member of the Iranian society for Health Genomics and Biotechnology, Eastern Association for Cancer Research (MEACR), National Cancer Research and Education Committee, Iran cancer Society, One of the Founders and member of the board of Directors in Health Biotechnology Society (Iran). He is Founder and first Editor-in-Chief of Avicenna Journal of Medical Biotechnology, and member of editorial board in journals. He has published 8 books, 1 book chapter, 1 news paper article, 3 abstracts, and 88 articles in journals contributed as author/co-author. He also worked on 6 research projects as Principal Investigator and Co-investigators. He successfully supervised 2 PhD degrees, and 17 Masters students.

Area of Interest:

Biomedical Sciences
100%
Marine Biology
62%
Endocrinology
90%
Gastroenterology
75%
Liver Diseases
55%

Education

2006

Ph.D.

Shahid Beheshti University, Iran

Endocrinology

Selected Publications

  1. Naemi, S., A.M. Ardekani, A. Ghaderi and N. Erfani, 2015. Investigation of E-cadherin expression in peripheral blood of patients with breast cancer in a population from southern Iran. Iran. South Med. J., 18: 117-124.

  2. Gharibiyan, A., S.A. Hashemi, M. Hadi, H. Abdolghafoorian and A.M. Ardekani, 2015. Serum/plasma DNA methylation pattern and early detection of breast cancer. Clin. Cancer Invest. J., 4: 120-128.
    CrossRef  |  Direct Link  |  

  3. Boroumand, M. and A.M. Ardekani, 2015. Alcohol and women’s health. J. Social Issues Humanit., 3: 2345-2633.

  4. Naeimi, S., N. Erfani, A.M. Ardekani and A. Ghaderi, 2014. Variation of IL-17A and IL-17F genes in patients with breast cancer in a population from southern Iran. Adv. Environ. Biol., 8: 892-897.

  5. Maghsoudi, N., R. Ghasemi, Z. Ghaempanah, A.M. Ardekani and E. Nooshinfar, 2014. Effect of chronic restraint stress on HPA axis activity and expression of BDNF and Trkb in the hippocampus of pregnant rats: Possible contribution in depression during pregnancy and postpartum period. Basic Clin. Neurosci. J., 5: 131-137.
    Direct Link  |  

  6. Ardekani, A.M., 2014. Genetically modified foods and health concerns. Iran. J. Biotechnol., 12: 1-2.
    CrossRef  |  Direct Link  |  

  7. Amanpour, T., A. Bazgir, A.M. Ardekani and R. Ghahremanzadeh, 2014. Pseudo five-component synthesis of 5-phenyldihydrospiro [diindenopyridine-indenoquinoxaline] dione derivatives via a one-pot condensation reaction. Monatshefte fur Chemie-Chem. Monthly, 145: 627-632.
    CrossRef  |  Direct Link  |  

  8. Alimardani, A., A.M. Ardekani and L.R. Astany, 2014. A bio-social review to mitigate the punishment of unwanted acts. Int. J. Criminol. Sociol., 3: 348-359.
    Direct Link  |  

  9. Saliminejad, K., T. Memariani, A.M. Ardekani, K. Kamali, H.E.Z. Pahlevanzadeh and H.R.K. Khorshid, 2013. Association study of the TNF-α-1031T/C and VEGF+450G/C polymorphisms with susceptibility to endometriosis. Gynecol. Endocrinol., 29: 974-977.
    CrossRef  |  Direct Link  |  

  10. Fattahi, S., A.M. Ardekani, E. Zabihi, Z. Abedian, A. Mostafazadeh, R. Pourbagher and H. Akhavan-Niaki, 2013. Antioxidant and apoptotic effects of an aqueous extract of Urtica dioica on the MCF-7 human breast cancer cell line. Asian Pac. J. Cancer Prev., 14: 5317-5323.
    PubMed  |  Direct Link  |  

  11. Pandamooz, S., A. Hadipour, H. Akhavan-Niaki, M. Pourghasem and Z. Abedian et al., 2012. Short exposure to collagenase and coculture with mouse embryonic pancreas improve human dermal fibroblast culture. Biotechnol. Applied Biochem., 59: 254-261.
    CrossRef  |  Direct Link  |  

  12. Khanaki, K., M. Nouri, M. Ardekani, A. Ghassemzadeh and V. Shahnazi et al., 2012. Evaluation of the relationship between endometriosis and omega-3 and omega-6 polyunsaturated fatty acids. Iranian Biomed. J., 16: 38-43.
    Direct Link  |  

  13. Khanaki, K., A.M. Ardekani, A. Ghassemzadeh, V. Shahnazi and M.R. Sadeghi et al., 2012. Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells. Iran. J. Reprod. Med., 10: 321-328.
    Direct Link  |  

  14. Ghorbian, S. and A.M. Ardekani, 2012. Non-invasive detection of esophageal cancer using genetic changes in circulating cell-free DNA. Avicenna J. Med. Biotechnol., 4: 3-13.
    Direct Link  |  

  15. Fard, S.S., M.J. Tehrani and A.M. Ardekani, 2012. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). Prostaglandins Leukotrienes Essential Fatty Acids, 87: 17-24.
    CrossRef  |  Direct Link  |  

  16. Ardekani, A.M.Z., M. Hashemi, M.S. Kish, A.A. Bagheri, S.B. Shekoohi and M. Mosadegh, 2012. Cancer drug treatment in Persian traditional medicine sources. Iran. Islamic Tradit. Med. J., 3: 3-18.

  17. Pandamooz, S., H. Akhavan-Niaki, N. Mousavi Kani, Z. Abedian, A.M. Ardekani, A. Hadipour and A. Mostafazadeh, 2011. Improved protocol for isolating dermal fibroblasts. Cell J., 13: 22-22.
    Direct Link  |  

  18. Mohajer, B. and A.M. Ardekani, 2011. Agricultural biotechnology and ethical dilemmas. Proceedings of the 2nd International Congress of Bioethics, February 5-7, 2011, NIGEB, Tehran, Iran -.

  19. Mirsalim, M. and A.M. Ardekani, 2011. Misuse of genetic information in criminal justice system. Proceedings of the 3rd International Congress on Medical Law, February 22-24, 2011, Shahid Beheshti University, Iran -.

  20. Mirsalim, M. and A.M. Ardekani, 2011. DNA testing in CRIMINAL justice system and ethical aspects. Proceedings of the 2nd International Congress of Bioethics, February 5-7, 2011, NIGEB, Tehran, Iran -.

  21. Maghari, B.M. and A.M. Ardekani, 2011. Genetically modified foods and social concerns. Avicenna J. Med. Biotechnol., 3: 109-117.

  22. Heidari, M., M. Farahpour, S. Talebi, H. Edalatkhah, A.H. Zarnani and A.M. Ardekani, 2011. Estradiol-induced differential GnRH gene exprpession in mouse uterus. Proceedings of the 27th Annual Meeting of ESHRE, July 2011, Stockholm, Sweden -.

  23. Ghaempanah, Z., A.M. Ardekani, R. Ghaemi, H. Edalatkhah, A. Meyfour and N. Maghsoudi, 2011. Stress-induced changes of BDNF expression in the hippocampus of pregnant Wistar rats. Proceedings of the 2nd Iranian Medical Genetics Conference, June, 20-21, 2011, Iran -.

  24. Farzaneh, F. and A.M. Ardekani, 2011. The role of mitochodria in cancer. Proceedings of the 2nd Iranian Medical Genetics Conference, June, 20-21, 2011, Iran -.

  25. Badr, M. and A.M. Ardekani, 2011. The role of stem cells in cancer. Proceedings of the 2nd Iranian Medical Genetics Conference, June, 20-21, 2011, Iran -.

  26. Ardekani, A.M., S.S. Fard, M.J. Tehrani and R. Ghahremanzade, 2011. Fenretinide, 1α,25(OH)2D3 and Bryostatin-1 induce cell cycle arrest, apoptosis and differentiation in human acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). Avicenna J. Med. Biotechnol., 3: 177-193.
    Direct Link  |  

  27. Ardekani, A.M., N. Maghsudi, A. Meyfour, R. Ghasemi, N. Lakpour, E. Nooshinfar and Z. Ghaempanah, 2011. Stress-induced proteomic changes in the hippocampus of pregnant wistar rats. Avicenna J. Med. Biotechnol., 3: 157-166.
    Direct Link  |  

  28. Ardekani, A.M., 2011. Ethical issues in biotechnology and genetic engineering. Proceedings of the 2nd International Congress of Bioethics, February 5-7, 2011, NIGEB, Tehran, Iran -.

  29. Ardekani, A.M., 2011. Ethical challenges in applications of reproductive biotechnologies. Cell J., 13: 10-10.
    Direct Link  |  

  30. Ahmadi, M. and A.M. Ardekani, 2011. Protection of genetic privacy in patients. Proceedings of the 3rd International Congress on Medical Law, February 22-24, 2011, Shahid Beheshti University, Iran -.

  31. Ahmadi, M. and A.M. Ardekani, 2011. Genetic privacy and genetic information of patients. Med. Genet. J., 5: 89-113.

  32. Abdollahpour, M., R. Tahamtan, F. Samani, Z. Deldar and M. Dehghan et al., 2011. Frequency of familial history in population with breast cancer referred to babol educational hospitals during 2007-2010. Cell J., 13: 26-27.
    Direct Link  |  

  33. Soudabeh, S., A.M. Ardakani, H. Mahshid, A.M. Mehdi and S.G. Haleh et al., 2010. Comparing seminal plasma biomarkers between normospermic and azoospermic men. J. Reprod. Infertil., 11: 39-46.
    Direct Link  |  

  34. Jabbari, S., M.R. Sadeghi, M.M. Akhondi, E.H. Azadeh and N. Amirjanati et al., 2010. Tyrosine phosphorylation pattern in sperm proteins isolated from normospermic and teratospermic men. J. Reprod. Infertil., 10: 185-191.
    Direct Link  |  

  35. Farzadtabar, M., S. Talebi, H. Edalatkhah, L. Eini, A.H. Zarnani, F. Razzaghi Kashani and A.M. Ardekani, 2010. The role of estradiol in regulation of GnRH receptor gene expression in mouse endometrial tissue. Proceedings of the 16th Congress of Iranian Society for Reproductive Medicine, March 3-5, 2010, Tehran, Iran -.

  36. Fard, S.S., M. Jeddi-Tehrani, M.M. Akhondi, M. Hashemi and A.M. Ardekani, 2010. Flow cytometric analysis of 4-HPR-induced apoptosis and cell cycle arrest in acute myelocytic leukemia cell line (NB-4). Avicenna J. Med. Biotech., 2: 53-61.
    Direct Link  |  

  37. Farahpour, M., S. Talebi, H. Edalatkhah, L. Eini, A.H. Zarnani, F. Razzaghi Kashani and A.M. Ardekani, 2010. Estradiol-induced differential GnRH gene expression in mouse uterus. Proceedings of the 16th Congress of Iranian Society for Reproductive Medicine, March 3-5, 2010, Tehran, Iran -.

  38. Charsooghee, A. and A.M. Ardekani, 2010. The genetics of anxiety disorders. Proceedings of the 11th Iranian Genetics Congress, May 22-24, 2010, Tehran, Iran -.

  39. Ardekani, A.M., M.M. Maghsoudi, R. Ghasemi, N. Lakpour, E. Nooshinfar and Z. Ghaempanah, 2010. Stress-induced proteomics changes in the hippocampus of pregnant Wistar rats. Proceedings of the 3rd Iranian Proteomics Congress, May 26-27, 2010, Pasteu Institute of Iran, Iran -.

  40. Ardekani, A.M. and S.A. Chaharsoughi, 2010. Infertility and stress. Proceedings of the 11th Royan International Congress on Reproductive Biomedicine, September 15-17, 2010, Tehran, Iran -.

  41. Ardekani, A.M. and M. Moslemi, 2010. The role of miRNAs and human diseases. Avicenna J. Med. Biotechnol., 2: 161-179.
    Direct Link  |  

  42. Sudabeh, J. and A.M. Ardekani, 2009. Genetics and ethical issues. Q. J. Med. Ethics, 2: 121-131.

  43. Shabnam, B. and A.M. Ardekani, 2009. Gene therapy and medical ethics. Q. J. Med. Ethics, 2: 189-198.

  44. Naeini, M.M. and A.M. Ardekani, 2009. Noncoding RNAs and cancer. Avicenna J. Med. Biotech., 1: 55-70.
    Direct Link  |  

  45. Jabbari, S., M.R. Sadeghi, N. Amirjanati, A.E. Habibi and N. Lakpour et al., 2009. Tyrosine phosphorylation pattern in sperm proteins isolated from normozoospermic and infertile teratozoospermic men. Proceedings of the 10th Iranian Congress of Biochemistry and the 3rd International Congress of Biochemistry and Molecular Biology, November 16-19, Tehran University -.

  46. Hashemi, R., J. Koosha and A.M. Ardekani, 2009. Ethical consideration of applications of cloning technology. Proceedings of the 10th Asian Bioethics Conference and 4th UNESCO Asia-Pacific School of Ethics Roundtable, April 26-29, 2009, Tehran, Iran -.

  47. Fard, S.S., M.M. Akhondi, M.J. Tehrani, L. Eini and A.M. Ardekani, 2009. Growth inhibition of acute leukemia cell lines by different classes of anticancer agents. Proceedings of the National Congress on New Cellular and Molecular Findings in Non Contagious Diseases, May 19-21, Iran -.

  48. Fard, S.S., M.M. Akhondi, M.J. Tehrani and A.M. Ardekani, 2009. Flow cytometric studies of apoptosis induced by Trichostatin A and 4-hydroxyphenylretinamide in acute lymphoblastic leukemia cell lines. Proceedings of the National Congress on New Cellular and Molecular Findings in Non Contagious Diseases, May 19-21, 2009, Babol, Iran -.

  49. Ardekani, A.M., S. Jabbari, M.R. Sadeghi, N. Amirjanati and A.E. Habibi et al., 2009. Phosphoproteomic pattern in normozoospermic and infertile teratozoospermic men. Proceedings of the HUPO 8th Annual World Congress, September 26-30, 2009, Toronto, Canada -.

  50. Ardekani, A.M., S. Jabbari, M.R. Sadeghi, N. Amirjanati and A.E. Habibi et al., 2009. Induction of protein tyrosine phosphorylation during capacitation in the spermatozoa of normozoospermic men. Proceedings of the 10th Iranian Congress of Biochemistry and the 3rd International Congress of Biochemistry and Molecular Biology, November 16-19, Tehran University -.

  51. Ardekani, A.M., 2009. Genetic technologies and ethics. J. Med. Ethics Hist. Med., 2: 11-11.
    Direct Link  |  

  52. Ardekani, A.M., 2009. Genetic behavior and culture. Med. Ethics J., 7: 65-84.

  53. Ardekani, A.M. and S. Jabbari, 2009. Nutrigenomics and cancer. Avicenna J. Med. Biotech., 1: 9-17.
    Direct Link  |  

  54. Dezfulian, A., A.M.Z. Ardekani, M.M. Aslani, H. Dabiri and M.R. Zali, 2008. Influence of the probiotic escherichia coli strain Nissle 1917 on the growth of different pathogenic bacteria isolated from patients with diarrhea. Gastroenterol. Hepatol. Bed Bench, 3: 113-117.

  55. Dezfulian, A., A.M. Ardekani, M.M. Aslani, H. Dabiri, Rezadehbashi and M.R. Zali, 2008. Study of inhibitory activity of E. coli Nissle 1917 as a probiotic on the growth of different bacterial strains. Proceedings of the 9th National Congress in Microbiology, March 4-6, Kerman -.

  56. Ardekani, A.M., M.M. Akhondi and M.R. Sadeghi, 2008. Application of genomics and proteomics technologies to early detection of cancer. Arch. Iran Med., 111: 427-434.
    PubMed  |  Direct Link  |  

  57. Ardekani, A.M., M.M. Akhondi and M.R. Sadeghi, 2008. Application of genomic and proteomic technologies to early detection of cancer. Arch. Iran. Med., 11: 427-434.
    PubMed  |  

  58. Ardekani, A.M., M. Hashemi, A.H. Karagah, N. Aali and M. Gaznavi et al., 2008. Treatment of fertility disorders in Persian traditional medicine. Proceedings of the International Congress of Traditional and Complementary Medicine, October 28-31, Sari -.

  59. Ardekani, A.M., M. Hashemi and S. Eshraghi, 2008. Comparative study of food classified in persian traditional medicine with new nutritional sciences. Proceedings of the International Congress of Traditional and Complementary Medicine, October 28-31, Sari -.

  60. Shahbodaghi, A., A. Ardekani, A. Moghadamnia and R. Pourkhoshbakht, 2007. A review of proteomics literature using ISI reports from 1990-2006. Proceedings of the 1st Iranian Proteomics Congress, February 21, 2007, Tehran University, Tehran, Iran -.

  61. Motevalizadeh, A.A., A. Ferial and N. Lakpour, 2007. Application of genomics and proteomics technologies to early diagnosis of reproductive organ cancers. J. Reprod. Infertil., 8: 259-278.
    Direct Link  |  

  62. Petricoin, E.F., V. Rajapaske, E.H. Herman, A.M. Ardekani and S. Ross et al., 2004. Toxicoproteomics: Serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection. Toxicol. Pathol., 32: 122-130.
    PubMed  |  

  63. Liotta, L.A., E.F. Petricoin, A.M. Ardekani, B.A. Hitt and P.J. Levine, et al., 2003. General keynote: Proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecologic Oncol., 88: S25-S28.
    CrossRef  |  

  64. Ardekani, A.M., E.F. Petricoin and J. Hackett, 2003. Molecular diagnostics: An FDA perspective. Expert Rev. Mol. Diag., 3: 129-140.
    CrossRef  |  

  65. Petricoin, E.F., D.K. Ornstein, C.P. Paweletz, A. Ardekani and P.S. Hackett et al., 2002. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst., 94: 1576-1578.
    PubMed  |  

  66. Petricoin, E.F., A.M. Ardekani, B.A. Hitt, P.J. Levine and V.A. Fusaro et al., 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359: 572-577.
    CrossRef  |  

  67. Michener, C.M., A.M. Ardekani, E.F. Petricoin, L.A. Liotta and E.C. Kohn, 2002. Genomics and proteomics: Application of novel technology to early detection and prevention of cancer. Cancer Detection Prev., 26: 249-255.
    Direct Link  |  

  68. Leak, L.V., E.F. Petricoin, M. Jones, C.P. Paweletz and A.M. Aredekani et al., 2002. Proteomic technologies to study diseases of the lymphatic vascular system. Ann. N.Y. Acad. Sci., 979: 211-228.
    PubMed  |  

  69. Ardekani, A.M., L.A. Liotta and E.F. Petricoin, 2002. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev. Mol. Diagn., 2: 312-320.
    PubMed  |  

  70. Ardekani, A.M., E.H. Herman, F.D. Sistare, L.A. Liotta and E.F. Petricoin, 2001. Molecular profiling of cancer and drug-induced toxicity using new proteomics technologies. Curr. Ther. Res., 62: 803-819.
    CrossRef  |  

  71. Ardekani, A.M., J.S. Greenberger and N. Jahroudi, 1998. Two repressor elements inhibit expression of the von willebrand factor gene promoter in vitro. Thromb. Homeost., 80: 488-494.
    PubMed  |  

  72. Ardekani, A.M., J.C. Romanelli and K.E. Mayo, 1998. Structure of the rat inhibin and activin βA-subunit gene and regulation in an ovarian granulosa cell line. Endocrinology, 139: 3271-3279.
    PubMed  |  

  73. Mayo, K.E., A. Mukherjee, A. Ardekani and I.W. Shu, 1997. Regulation of inhibin and activin subunit gene expression in ovarian granulosa cells. Biol. Reprod., 56: M20-M20.

  74. Jahroudi, N., A.M. Ardekani and J.S. Greenberger, 1996. Ionizing irradiation increases transcription of the von willebrand factor gene in endothelial cells. Blood, 88: 3801-3814.
    PubMed  |  

  75. Jahroudi, N., A.M. Ardekani and J.S. Greenberger, 1996. An NF1-like protein functions as a repressor of the von Willedbrand factor promoter. J. Biol. Chem., 271: 21413-21421.
    PubMed  |  

  76. Jahroudi, N., A. Ardekani and J.S. Greenberger, 1996. Two repressor elements regulate endothelial-specific activation of the VWF promoter. Blood, 88: 2028-2028.

  77. Bahrmand, A.R., H. Nekoui and A.M. Ardekani, 1996. New solid culture media for growing borrelia persica and borrelia microti. Rev. Cubana Med. Trop., 48: 40-44.
    PubMed  |  

  78. Jahroudi, N., A. Ardekani and J.S. Greenberger, 1995. The von-willebrand-factor gene-transcription is increased in response to ionizing irradiation. Exp. Hematol., 23: 779-779.

  79. Jahroudi, N., A. Ardekani and J.S. Greenberger, 1995. Ionizing irradiation increases transcription of the von willebrand factor gene in endothelial cells. Blood, 86: 3486-3486.

  80. Jahroudi, N., A. Ardekani and J.S. Greenberger, 1995. An NF-1-like protein functions as a repressor of the vWf promoter. Blood, 86: 307-307.

  81. Van Dyke, K., P. Allender, L. Wu, J. Gutierrez, J. Garcia, A.M. Ardekani and W. Karo, 1990. Luminol-or lucigenin-coated micropolystyrene beads, a single reagent to study opsonin-independent phagocytosis by cellular chemiluminescence: Reaction with human neutrophils, monocytes and differentiated HL-60 cells. Microchem. J., 41: 196-209.

  82. Van Dyke, K., P. Allender, L. Wu, J. Gutierrez, J. Garcia, A.M. Ardekani and W. Karo, 1990. Luminol or lucigenin-coated polystyrene beads, a single reagent to study opsonin independent phagocytosis by cellular L-60 cells. Microchem. J., 41: 196-209.

  83. Ardekani, A.M., S.J. Walker, S.J. Donohue, R.E. Stitzel, J.M. Conners and K.E. Vrana, 1989. Adrenocorticotropin and corticosterone levels in pre-weaning spontaneously hypertensive rats. Life Sci., 44: 919-925.
    CrossRef  |  

  84. Ardekani, A.M., P. de Baetselier and K. Van Dyke, 1989. Chemiluminescent response in murine peritoneal macrophage hybridoma-cell line (2C11-12) primed with lipopolysaccharide (LPS) and Interferon-β. Microchem. J., 40: 139-151.

  85. Ardekani, A.M. and K. Van Dyke, 1989. Myeloperoxidase involvement in PMA induced chemiluminescence in retinoic-acid-differentiated HL-60 cells. Microchem. J., 39: 317-329.
    CrossRef  |  

  86. Peden, D., K. van Dyke, A. Ardekani, M. Mullett, D. Myerberg and C. van Dyke, 1987. Diminished chemiluminescent responses of polymorphonuclear leukocytes in preterm and very low birthweight neonates. J. Pediatrics, 111: 904-905.

  87. Peden, D., K. van Dyke, A. Ardekani, M. Mullett and W. Neal, 1986. Studies of neonatal polymorphonuclear leukocyte function using a novel microanalytic chemiluminescence technique. Microchem. J., 34: 222-229.
    Direct Link  |  

  88. Ardekani, A.M., D. English and K. van Dyke, 1986. The inhibition of luminol-dependent chemiluminescence of lipoxygenase, myeloperoxidase and human neutrophils by dipyridamole. Microchem. J., 33: 309-315.